Ara
Toplam kayıt 68, listelenen: 21-30
Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis
(2017)
Objective The aim of the study was to investigate the prognostic factors for survival and treatment-related toxicities in older (65 years) cervical cancer patients treated with definitive chemoradiotherapy. In addition, ...
Predicting Tumor Recurrence in Patients with Cervical Carcinoma Treated with Definitive Chemoradiotherapy: Value Of Quantitative Histogram Analysis On Diffusion-Weighted MR Images
(2017)
Background: Further research is required for evaluating the use of ADC histogram analysis in more advanced stages of cervical cancer treated with definitive chemoradiotherapy (CRT).
Purpose: To investigate the utility ...
Multifocal Soft Tissue Langerhans' Cell Histiocytosis Treated with PET-CT Based Conformal Radiotherapy
(2015)
Langerhans' cell histiocytosis (LCH) is a proliferative disorder of Langerhans cells, which is seen extremely rarely in adults. Conventional imaging modalities, such as skeletal surveys and bone scans, were accepted to be ...
Correlation of Clinical Risk Factors with Diffusion-Weighted Magnetic Resonance Images in Prostate Cancer Patients Treated with Definitive Radiotherapy
(2015)
This study is aimed to correlate apparent diffusion coefficient (ADC) values and clinical T-stage, serum PSA, pathology Gleason scores. We also further analyzed whether ADC values could be used to appropriately define the ...
Practice Patterns For Oropharyngeal Cancer in Radiation Oncology Centers of Turkey
(2014)
Aims and background. The aim of the study was to review the current clinical practices of radiation oncologists involved in the treatment of oropharyngeal cancer.
Methods and study design. The daily practices of radiation ...
Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse
(2020)
Background: Ovarian cancer is fifth leading cause of the cancer related death in women. Platin based doublet regimen plus bevacizumab is standard treatment in relapse. The primary aim of this study is to define clinicopathological ...